CoChat
Cited by 238

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

The emerging roles of serine protease cascades in the epidermis

Ovaere, Petra, Lippens, Saskia, Vandenabeele, Peter, Declercq, Wim · 2009 · Trends in Biochemical Sciences

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tibs.2009.08.001

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 104

  1. Norlen, 2003, A cryotransmission electron microscopy study of skin barrier formation, J. Invest. Dermatol., 120, 555, 10.1046/j.1523-1747.2003.12102.x · DOI
  2. Presland, 1995, Characterization of two distinct calcium-binding sites in the amino-terminus of human profilaggrin, J. Invest. Dermatol., 104, 218, 10.1111/1523-1747.ep12612770 · DOI
  3. Steven, 1994, Protein composition of cornified cell envelopes of epidermal keratinocytes, J. Cell Sci., 107, 693, 10.1242/jcs.107.2.693 · DOI · Paper page
  4. Kezic, 2008, Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum, J. Invest. Dermatol., 128, 2117, 10.1038/jid.2008.29 · DOI · Paper page
  5. Smith, 2006, Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris, Nat. Genet., 38, 337, 10.1038/ng1743 · DOI · Paper page
  6. McGrath, 2008, The filaggrin story: novel insights into skin-barrier function and disease, Trends Mol. Med., 14, 20, 10.1016/j.molmed.2007.10.006 · DOI · Paper page
  7. Presland, 2000, Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris, J. Invest. Dermatol., 115, 1072, 10.1046/j.1523-1747.2000.00178.x · DOI · Paper page
  8. Netzel-Arnett, 2006, Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation, J. Biol. Chem., 281, 32941, 10.1074/jbc.C600208200 · DOI · Paper page
  9. Takeuchi, 1999, Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue, Proc. Natl. Acad. Sci. U.S.A., 96, 11054, 10.1073/pnas.96.20.11054 · doi:10.1073/pnas.96.20.11054
  10. Kojima, 2009, The activity of a type II transmembrane serine protease, matriptase, is dependent solely on the catalytic domain, Biosci. Biotech. Biochem., 73, 454, 10.1271/bbb.80713 · doi:10.1271/bbb.80713
  11. Bugge, 2007, Matriptase-dependent cell surface proteolysis in epithelial development and pathogenesis, Front. Biosci., 12, 5060, 10.2741/2448 · DOI
  12. Lin, 2008, Zymogen activation, inhibition, and ectodomain shedding of matriptase, Front. Biosci., 13, 621, 10.2741/2707 · doi:10.2741/2707
  13. Lee, 2007, Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain, Am. J. Physiol, 293, C95, 10.1152/ajpcell.00611.2006 · doi:10.1152/ajpcell.00611.2006
  14. List, 2002, Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis, Oncogene, 21, 3765, 10.1038/sj.onc.1205502 · DOI · Paper page
  15. List, 2003, Loss of proteolytically processed filaggrin caused by epidermal deletion of matriptase/MT-SP1, J. Cell Biol., 163, 901, 10.1083/jcb.200304161 · DOI · Paper page
  16. Alef, 2009, Ichthyosis, follicular atrophoderma, and hypotrichosis caused by mutations in ST14 is associated with impaired profilaggrin processing, J. Invest. Dermatol., 129, 862, 10.1038/jid.2008.311 · DOI
  17. Basel-Vanagaite, 2007, Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase, Am. J. Hum. Genet., 80, 467, 10.1086/512487 · DOI · Paper page
  18. List, 2007, Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase, J. Cell Physiol, 10.1002/jcp.21115 · DOI
  19. Leyvraz, 2005, The epidermal barrier function is dependent on the serine protease CAP1/Prss8, J. Cell Biol., 170, 487, 10.1083/jcb.200501038 · DOI · Paper page
  20. Vuagniaux, 2002, Synergistic activation of ENaC by three membrane-bound channel-activating serine proteases (mCAP1, mCAP2, and mCAP3) and serum- and glucocorticoid-regulated kinase (Sgk1) in Xenopus oocytes, J. Gen. Physiol., 120, 191, 10.1085/jgp.20028598 · DOI · Paper page
  21. Mauro, 2002, The ENaC channel is required for normal epidermal differentiation, J. Invest. Dermatol., 118, 589, 10.1046/j.1523-1747.2002.01721.x · DOI
  22. Planes, 2007, Regulation of the epithelial Na+ channel by peptidases, Curr. Top. Dev. Biol., 78, 23, 10.1016/S0070-2153(06)78002-4 · DOI
  23. Bruns, 2007, Epithelial Na+ channels are fully activated by furin- and prostasin-dependent release of an inhibitory peptide from the gamma-subunit, J. Biol. Chem., 282, 6153, 10.1074/jbc.M610636200 · DOI · Paper page
  24. Denda, 2006, Expression of voltage-gated calcium channel subunit alpha1C in epidermal keratinocytes and effects of agonist and antagonists of the channel on skin barrier homeostasis, Exp. Dermatol., 15, 455, 10.1111/j.0906-6705.2006.00430.x · doi:10.1111/j.0906-6705.2006.00430.x
  25. Guitard, 2004, A nonconventional look at ionic fluxes in the skin: lessons from genetically modified mice, News Physiol. Sci., 19, 75
  26. Yamazaki, 1997, Cytoplasmic processing of human profilaggrin by active mu-calpain, Biochem. Biophys. Res. Commun., 235, 652, 10.1006/bbrc.1997.6809 · DOI
  27. Pearton, 2001, Proprotein convertase expression and localization in epidermis: evidence for multiple roles and substrates, Exp. Dermatol., 10, 193, 10.1034/j.1600-0625.2001.010003193.x · DOI
  28. Resing, 1993, Independent regulation of two cytoplasmic processing stages of the intermediate filament-associated protein filaggrin and role of Ca2+ in the second stage, J. Biol. Chem., 268, 25139, 10.1016/S0021-9258(19)74580-3 · DOI
  29. Charles, 2008, Postnatal requirement of the epithelial sodium channel for maintenance of epidermal barrier function, J. Biol. Chem., 283, 2622, 10.1074/jbc.M708829200 · DOI
  30. Yamamura, 2008, Epithelial Na+ channel delta subunit mediates acid-induced ATP release in the human skin, Biochemical Biophys. Res. Commun., 373, 155, 10.1016/j.bbrc.2008.06.008 · DOI
  31. Denecker, 2008, Caspase-14 reveals its secrets, J. Cell Biol., 180, 451, 10.1083/jcb.200709098 · DOI · Paper page
  32. Fan, 2005, Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin, J. Biol. Chem., 280, 34513, 10.1074/jbc.M502119200 · doi:10.1074/jbc.m502119200
  33. Lin, 1999, Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk, J. Biol. Chem., 274, 18237, 10.1074/jbc.274.26.18237 · doi:10.1074/jbc.274.26.18237
  34. Oberst, 2005, HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease, Am. J. Physiol., 289, C462, 10.1152/ajpcell.00076.2005 · DOI
  35. Oberst, 2003, The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor, J. Biol. Chem., 278, 26773, 10.1074/jbc.M304282200 · doi:10.1074/jbc.m304282200
  36. Szabo, 2007, Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development, Oncogene, 26, 1546, 10.1038/sj.onc.1209966 · DOI
  37. Carney, 2007, Inactivation of serine protease Matriptase1a by its inhibitor Hai1 is required for epithelial integrity of the zebrafish epidermis, Development (Cambridge, England), 134, 3461, 10.1242/dev.004556 · DOI
  38. List, 2005, Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation, Genes Dev., 19, 1934, 10.1101/gad.1300705 · DOI · Paper page
  39. Kilpatrick, 2006, Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase, Blood, 108, 2616, 10.1182/blood-2006-02-001073 · DOI
  40. Nagaike, 2008, Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice, American J. Pathol., 173, 1464, 10.2353/ajpath.2008.071142 · DOI
  41. Lundstrom, 1988, Cell shedding from human plantar skin in vitro: evidence of its dependence on endogenous proteolysis, J. Invest. Dermatol., 91, 340, 10.1111/1523-1747.ep12475679 · DOI
  42. Brattsand, 2005, A proteolytic cascade of kallikreins in the stratum corneum, J. Invest. Dermatol., 124, 198, 10.1111/j.0022-202X.2004.23547.x · DOI · Paper page
  43. Stefansson, 2006, Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum, Biol. Chem., 387, 761, 10.1515/BC.2006.095 · DOI
  44. Komatsu, 2005, Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases, Brit. J. Dermatol., 153, 274, 10.1111/j.1365-2133.2005.06754.x · DOI
  45. Lundwall, 2008, Kallikrein-related peptidases, Cell Mol. Life Sci., 65, 2019, 10.1007/s00018-008-8024-3 · DOI
  46. Sondell, 1996, Association between expression of stratum corneum chymotryptic enzyme and pathological keratinization in human oral mucosa, Acta Derm. Venereol., 76, 177, 10.2340/0001555576177181 · doi:10.2340/0001555576177181
  47. Ekholm, 1998, The expression of stratum corneum chymotryptic enzyme in human anagen hair follicles: further evidence for its involvement in desquamation-like processes, Brit. J. Dermatol., 139, 585, 10.1046/j.1365-2133.1998.02452.x · DOI
  48. Kishi, 2004, Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids, Clin. Chem., 50, 709, 10.1373/clinchem.2003.029538 · doi:10.1373/clinchem.2003.029538
  49. Ishida-Yamamoto, 2005, LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum, J. Invest. Dermatol., 124, 360, 10.1111/j.0022-202X.2004.23583.x · DOI · Paper page
  50. Ishida-Yamamoto, 2004, Epidermal lamellar granules transport different cargoes as distinct aggregates, J. Invest. Dermatol., 122, 1137, 10.1111/j.0022-202X.2004.22515.x · DOI · Paper page
  51. Sondell, 1995, Evidence that stratum corneum chymotryptic enzyme is transported to the stratum corneum extracellular space via lamellar bodies, J. Invest. Dermatol., 104, 819, 10.1111/1523-1747.ep12607007 · DOI
  52. Watkinson, 2001, Water modulation of stratum corneum chymotryptic enzyme activity and desquamation, Arch Dermatol Res, 293, 470, 10.1007/s004030100257 · DOI
  53. Caubet, 2004, Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7, J. Invest. Dermatol., 122, 1235, 10.1111/j.0022-202X.2004.22512.x · DOI · Paper page
  54. Kirihara, 2003, Prolonged recovery of ultraviolet B-irradiated skin in neuropsin (KLK8)-deficient mice, Brit. J. Dermatol., 149, 700, 10.1046/j.1365-2133.2003.05484.x · DOI
  55. Kishibe, 2007, Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins, J. Biol. Chem., 282, 5834, 10.1074/jbc.M607998200 · DOI
  56. Kreutzmann, 2004, Recombinant production, purification and biochemical characterization of domain 6 of LEKTI: a temporary Kazal-type-related serine proteinase inhibitor, J. Chromatogr., 803, 75, 10.1016/j.jchromb.2003.07.016 · DOI
  57. Mitsudo, 2003, Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis, Biochemistry, 42, 3874, 10.1021/bi027029v · doi:10.1021/bi027029v
  58. Borgono, 2007, A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation, J. Biol. Chem., 282, 3640, 10.1074/jbc.M607567200 · DOI · Paper page
  59. Deraison, 2007, LEKTI Fragments Specifically Inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction, Mol. Biol. Cell, 10.1091/mbc.E07-02-0124 · DOI · Paper page
  60. Egelrud, 2005, hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6, Brit. J. Dermatol., 153, 1200, 10.1111/j.1365-2133.2005.06834.x · DOI
  61. Fernandez, 2008, Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6), J. Mol. Biol., 377, 1488, 10.1016/j.jmb.2008.01.089 · DOI
  62. Schechter, 2005, Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI), Biol. Chem., 386, 1173, 10.1515/BC.2005.134 · DOI
  63. Vitzithum, 2008, LEKTI domain 15 is a functional Kazal-type proteinase inhibitor, Protein Expr. Purif., 57, 45, 10.1016/j.pep.2007.08.012 · doi:10.1016/j.pep.2007.08.012
  64. Bitoun, 2003, LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome, Hum. Mol.Genet., 12, 2417, 10.1093/hmg/ddg247 · DOI · Paper page
  65. Tartaglia-Polcini, 2006, SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing, J. Invest. Dermatol., 126, 315, 10.1038/sj.jid.5700015 · DOI
  66. Hachem, 2006, Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome, J. Invest. Dermatol., 126, 1609, 10.1038/sj.jid.5700288 · DOI · Paper page
  67. Chavanas, 2000, Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome, Nat. Genet., 25, 141, 10.1038/75977 · DOI · Paper page
  68. Komatsu, 2008, Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients, J. Invest. Dermatol., 128, 1148, 10.1038/sj.jid.5701153 · DOI
  69. Sprecher, 2001, The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis, The J. Invest. Dermatol., 117, 179, 10.1046/j.1523-1747.2001.01389.x · DOI · Paper page
  70. Sun, 2006, Netherton syndrome: a case report and review of the literature, Int. J. Dermatol., 45, 693, 10.1111/j.1365-4632.2005.02637.x · doi:10.1111/j.1365-4632.2005.02637.x
  71. Descargues, 2006, Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome, J. Invest. Dermatol., 126, 1622, 10.1038/sj.jid.5700284 · DOI · Paper page
  72. Ny, 2004, Epidermal hyperproliferation and decreased skin barrier function in mice overexpressing stratum corneum chymotryptic enzyme, Acta Derm. Venereol., 84, 18, 10.1080/00015550310005924 · DOI
  73. Descargues, 2005, Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity, Nat. Genet., 37, 56, 10.1038/ng1493 · DOI · Paper page
  74. Hewett, 2005, Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome, Hum. Mol. Genet., 14, 335, 10.1093/hmg/ddi030 · DOI
  75. Brattsand, 2009, SPINK9: a selective, skin-specific Kazal-type serine protease inhibitor, J. Invest. Dermatol., 129, 1656, 10.1038/jid.2008.448 · doi:10.1038/jid.2008.448
  76. Meyer-Hoffert, 2009, Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor, PLoS ONE, 4, e4372, 10.1371/journal.pone.0004372 · DOI
  77. Galliano, 2006, A novel protease inhibitor of the alpha2-macroglobulin family expressed in the human epidermis, J. Biol. Chem., 281, 5780, 10.1074/jbc.M508017200 · DOI
  78. Armstrong, 2006, Proteases and protease inhibitors: a balance of activities in host-pathogen interaction, Immunobiology, 211, 263, 10.1016/j.imbio.2006.01.002 · DOI
  79. Feldman, 1985, Model of alpha 2-macroglobulin structure and function, Proc. Natl. Acad. Sci. U.S.A., 82, 5700, 10.1073/pnas.82.17.5700 · doi:10.1073/pnas.82.17.5700
  80. Bieth, 1981, Inhibition of alpha 2-macroglobulin-bound trypsin by soybean trypsin inhibitor, J. Biol. Chem., 256, 7954, 10.1016/S0021-9258(18)43372-8 · doi:10.1016/s0021-9258(18)43372-8
  81. Enghild, 1989, Proteinase binding and inhibition by the monomeric alpha-macroglobulin rat alpha 1-inhibitor-3, J. Biol. Chem., 264, 11428, 10.1016/S0021-9258(18)60482-X · doi:10.1016/s0021-9258(18)60482-x
  82. Galliano, 2008, Binding of alpha2ML1 to the low density lipoprotein receptor-related protein 1 (LRP1) reveals a new role for LRP1 in the human epidermis, PLoS ONE, 3, e2729, 10.1371/journal.pone.0002729 · DOI
  83. Oikonomopoulou, 2006, Proteinase-activated receptors, targets for kallikrein signaling, J. Biol. Chem., 281, 32095, 10.1074/jbc.M513138200 · DOI · Paper page
  84. Seeliger, 2003, Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo, FASEB J., 17, 1871, 10.1096/fj.02-1112com · DOI
  85. Cork, 2006, New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions, J. Allergy Clin. Immunol., 118, 3, 10.1016/j.jaci.2006.04.042 · DOI · Paper page
  86. Nylander-Lundqvist, 1997, Formation of active IL-1 beta from pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme in vitro, Acta Derm. Venereol., 77, 203, 10.2340/0001555577203206 · DOI
  87. Vasilopoulos, 2004, Genetic association between an AACC insertion in the 3’UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis, J. Invest. Dermatol., 123, 62, 10.1111/j.0022-202X.2004.22708.x · DOI · Paper page
  88. Yamasaki, 2006, Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin, FASEB J., 20, 2068, 10.1096/fj.06-6075com · DOI · Paper page
  89. Schalkwijk, 1999, The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core, Biochem. J., 340, 569, 10.1042/0264-6021:3400569 · doi:10.1042/0264-6021:3400569 · Paper page
  90. Franzke, 1996, Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation, J. Biol. Chem., 271, 21886, 10.1074/jbc.271.36.21886 · DOI
  91. Wingens, 1998, Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes, J. Invest. Dermatol., 111, 996, 10.1046/j.1523-1747.1998.00425.x · DOI
  92. Thompson, 1986, Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase, Proc. Natl. Acad. Sci. U.S.A., 83, 6692, 10.1073/pnas.83.18.6692 · DOI · Paper page
  93. Ekholm, 1999, Stratum corneum chymotryptic enzyme in psoriasis, Arch. Dermatol. Res., 291, 195, 10.1007/s004030050393 · DOI
  94. Allen, 2001, Corneodesmosin expression in psoriasis vulgaris differs from normal skin and other inflammatory skin disorders, Lab. Invest., 81, 969, 10.1038/labinvest.3780309 · DOI
  95. Wiedow, 1998, Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes, Biochem. Biophys. Res. Commun., 248, 904, 10.1006/bbrc.1998.9069 · DOI · Paper page
  96. Menon, 1985, Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry, J. Invest. Dermatol., 84, 508, 10.1111/1523-1747.ep12273485 · DOI · Paper page
  97. Menon, 1992, Localization of calcium in murine epidermis following disruption and repair of the permeability barrier, Cell Tissue Res., 270, 503, 10.1007/BF00645052 · DOI · Paper page
  98. Demerjian, 2008, Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2, Am. J. Pathol., 172, 86, 10.2353/ajpath.2008.070161 · DOI
  99. Hachem, 2006, Serine protease signaling of epidermal permeability barrier homeostasis, J. Invest. Dermatol., 126, 2074, 10.1038/sj.jid.5700351 · DOI · Paper page
  100. Ohman, 1994, In vivo studies concerning a pH gradient in human stratum corneum and upper epidermis, Acta Derm. Venereol., 74, 375, 10.2340/0001555574375379 · DOI · Paper page
  101. Gibbs, 1997, Culture of reconstructed epidermis in a defined medium at 33 degrees C shows a delayed epidermal maturation, prolonged lifespan and improved stratum corneum, Arch. Dermatol. Res., 289, 585, 10.1007/s004030050244 · DOI
  102. Vaccaro, 1985, Characterization of human glucosylsphingosine glucosyl hydrolase and comparison with glucosylceramidase, Eur. J. Biochem., 146, 315, 10.1111/j.1432-1033.1985.tb08655.x · doi:10.1111/j.1432-1033.1985.tb08655.x
  103. Hachem, 2005, Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity, J. Invest. Dermatol., 125, 510, 10.1111/j.0022-202X.2005.23838.x · DOI · Paper page
  104. Rippke, 2002, The acidic milieu of the horny layer: new findings on the physiology and pathophysiology of skin pH, Am. J. Clin. Dermatol., 3, 261, 10.2165/00128071-200203040-00004 · DOI · Paper page

Cited by

See all 238

Metadata

Authors
Ovaere, P., Lippens, S., Vandenabeele, P., & Declercq, W.
Venue
Trends in Biochemical Sciences
Publisher
Elsevier BV
Published
2009-09
Volume
34
Issue
9
Pages
453-463
ISSN
0968-0004 (ISSN-L)
OpenAlex
W2156034391
Cited by
238
References
8
FWCI
1.04
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.